Albiglutide Powder

Albiglutide Powder GMP Manufacturer in China | High-Purity Long-Acting GLP-1 Fusion Protein API Supplier for Type 2 Diabetes Research, Metabolic Disease Studies & Once-Weekly Injection Development

Key Highlights

• Long-acting GLP-1 activity with 7-day steady glycemic control
• Glucose-dependent insulin release minimizes hypoglycemia risk
• Suppresses glucagon to stabilize fasting and postprandial blood sugar
• Delays gastric emptying and enhances satiety for mild weight loss
• DPP-4 resistant structure ensures persistent in-vivo efficacy
•  Neutral cardiovascular profile for long-term metabolic research

Albiglutide Powder is a recombinant long-acting GLP-1 receptor agonist fusion protein composed of two copies of modified human GLP-1 (7–36) covalently fused to human serum albumin.It was originally approved for type 2 diabetes treatment and is now widely used in metabolic research and long-acting GLP-1 formulation development studies.

This product is supplied as a white to off-white powder manufactured under strict GMP standards, using recombinant expression followed by multi-step chromatographic purification, desalting, and sterile processing.

Protein identity and structural integrity are confirmed by SEC-HPLC, mass spectrometry, and sequence analysis, ensuring high batch consistency and reproducibility.

1. How Does It Enable Once-Weekly Dosing?

Albumin fusion significantly increases hydrodynamic size and reduces renal clearance, extending systemic exposure and enabling once-weekly dosing profiles in research models.

2. How Does It Improve Glucose-Dependent Insulin Secretion?

It activates GLP-1 receptors on pancreatic β-cells, enhancing insulin release in a glucose-dependent manner, thereby reducing the risk of hypoglycemia.

3. How Does It Improve Glycemic Control?

It suppresses glucagon secretion, reduces hepatic glucose production, and stabilizes both fasting and postprandial glucose levels.

4. How Does It Support Weight Regulation Research?

It modulates hypothalamic appetite signaling pathways, enhancing satiety and reducing caloric intake, supporting metabolic disease studies.

5. How Does Albumin Fusion Extend Stability?

Albumin fusion protects GLP-1 sequences from rapid enzymatic degradation and significantly prolongs circulating half-life.

6. Why Is It Suitable for Long-Acting Injectable Development?

Its high structural stability and low aggregation tendency make it suitable for development of long-acting injectable formulations.

• Long-acting GLP-1 diabetes drug development
• Once-weekly injection formulation research
• Metabolic syndrome and obesity studies
• GLP-1 fusion protein mechanism research
• Combination therapy development
• Long-acting peptide delivery system design

1. How Does It Activate GLP-1 Receptor Signaling?

It binds to GLP-1 receptors on pancreatic β-cells and activates intracellular cAMP signaling pathways, enhancing glucose-dependent insulin secretion.

2. How Does It Regulate Glucagon Secretion?

It inhibits pancreatic α-cell activity, reducing glucagon release and decreasing hepatic glucose output.

3. How Does It Affect Appetite Regulation?

It activates GLP-1 receptors in the hypothalamus, increasing satiety and reducing food intake.

4. How Does Albumin Fusion Improve Pharmacokinetics?

Albumin fusion increases molecular size, reduces renal filtration, and extends systemic circulation time, supporting once-weekly dosing.

• GMP-certified biopharmaceutical cleanroom production
• Controlled recombinant expression and purification system
• Full batch traceability from upstream to final API
• Long-term and accelerated stability
• Optional third-party analytical verification available

Hot Tags: albiglutide powder, China albiglutide powder manufacturers, suppliers, factory, Liraglutide Peptide Powder, Lixisenatide Powder, Myristoyl Pentapeptide 17 Powder, Oxytocin Powder, Palmitoyl Tripeptide 5 Powder, Pinealon Peptide Powder